Profile data is unavailable for this security.
About the company
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
- Revenue in USD (TTM)1.13bn
- Net income in USD-80.67m
- Incorporated2004
- Employees560.00
- LocationPrestige Consumer Healthcare Inc660 White Plains RdTARRYTOWN 10591-5139United StatesUSA
- Phone+1 (914) 524-6800
- Fax+1 (302) 674-5266
- Websitehttps://www.prestigebrands.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc | 1.13bn | -80.67m | 3.47bn | 560.00 | -- | 2.17 | -- | 3.06 | -1.64 | -1.64 | 22.66 | 32.24 | 0.32 | 3.31 | 6.85 | 2,025,420.00 | -2.28 | 2.24 | -2.37 | 2.33 | 55.23 | 57.11 | -7.11 | 7.74 | 1.92 | 4.93 | 0.4288 | 0.00 | 3.76 | 1.61 | -140.07 | -- | -9.08 | -- |
| Walgreens Boots Alliance Inc | 144.60bn | -6.04bn | 15.72bn | 206.00k | -- | 1.17 | -- | 0.1087 | -7.00 | -7.00 | 167.51 | 15.63 | 1.57 | 13.60 | 24.24 | 701,922.30 | -13.96 | 1.39 | -21.26 | 2.05 | 18.56 | 21.29 | -8.92 | 0.8774 | 0.3213 | 1.82 | 0.4054 | 113.11 | 4.81 | 1.12 | -171.02 | -- | 9.14 | 3.71 |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 7.95m | 16.01% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 5.67m | 11.42% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 3.43m | 6.92% |
| Macquarie Investment Management Business Trustas of 31 Dec 2023 | 3.06m | 6.17% |
| Ariel Investments LLCas of 31 Dec 2023 | 2.56m | 5.15% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.00m | 4.03% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.15m | 2.32% |
| Westwood Management Corp. (Texas)as of 31 Dec 2023 | 1.12m | 2.27% |
| Massachusetts Financial Services Co.as of 31 Dec 2023 | 1.04m | 2.09% |
| Allspring Global Investments LLCas of 31 Mar 2024 | 1.02m | 2.05% |
